NOAEL Studies
UV Filter / Sunscreen
TriAsorB NOAEL Studies
INCI: PHENYLENE BIS-DIPHENYLTRIAZINE
CAS: 55514-22-2
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
SCCS Opinion 8 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =48.5 | % | rat | oral | 2-week | repeated dose toxicity | p.36 |
| SCCS Opinion | NOAEL | =54 | mg/kg bw/day | - | inhalation | 14-day | NOAEL study | p.41 |
| SCCS Opinion | NOAEL | =80 | mg/kg bw | rat | dermal | 90 day | irritation | p.73 |
| SCCS Opinion | NOAEL | =464 | mg/kg bw/day | rat | oral | prenatal | developmental toxicity | p.52 |
| SCCS Opinion | NOAEL | =464 | mg/kg bw/d | - | oral | developmental | reproductive toxicity | p.67 |
| SCCS Opinion | NOAEL | =485 | mg/kg/day | rat | oral | 13 weeks | repeated dose toxicity | p.36 |
| SCCS Opinion | NOAEL | =1000 | mg/kg bw/day | - | - | Developmental | repeated dose toxicity | p.36 |
| SCCS Opinion | NOAEL | =1000 | mg/kg/day | - | - | - | NOAEL study | p.50 |
ECHA 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ECHA | NOEL | =1000 | mg/kg bw/day | Rat | oral | short-term; 5 days | short-term | QUALITY=1 (reliable without restriction); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/66a7cb54e4b0a7c65d225bce; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/registration-dossier/-/registered-dossier/6106/7/6/2?documentUUID=4b4753c6-29c3-4692-aadf-22c699e4c870; YEAR=2012; ORIGINAL_YEAR=2012; STUDY_GROUP=ECHA IUCLID:15839320:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_4179f756f5efa114acc49834735cf108 |
Regulatory source 14 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 54 | mg/kg bw/day | - | inhalation | 14-day | - | p.41 |
| Regulatory source | - | 1000 | mg/kg/day | - | - | - | - | p.50 |
| Regulatory source | - | 1000 | mg/kg/day | rat | oral | 4-week | - | p.66 |
| Regulatory source | developmental toxicity | 464 | mg/kg bw/day | rat | oral | prenatal | developmental toxicity | p.52 |
| Regulatory source | developmental toxicity | 1000 | mg/kg bw/day | - | - | prenatal | developmental toxicity | p.52 |
| Regulatory source | irritation | 80 | mg/kg bw | rat | dermal | 90 day | irritation | p.73 |
| Regulatory source | repeated dose toxicity | 48.5 | % | rat | oral | 2-week | repeated dose toxicity | p.36 |
| Regulatory source | repeated dose toxicity | 54 | mg/kg bw/day | rat | inhalation | subacute | repeated dose toxicity | p.66 |
| Regulatory source | repeated dose toxicity | 485 | mg/kg/day | rat | oral | 13 weeks | repeated dose toxicity | p.36 |
| Regulatory source | repeated dose toxicity | 1000 | mg/kg bw/day | - | - | Developmental | repeated dose toxicity | p.36 |
| Regulatory source | repeated dose toxicity | 1000 | mg/kg/day | rat | oral | 13-week | repeated dose toxicity | p.66 |
| Regulatory source | repeated dose toxicity | 1000 | mg/kg/day | rat | oral | developmental | repeated dose toxicity | p.66 |
| Regulatory source | reproductive toxicity | 464 | mg/kg bw/d | - | oral | developmental | reproductive toxicity | p.67 |
| Regulatory source | reproductive toxicity | 1000 | mg/kg/day | rat | - | Developmental | reproductive toxicity | p.51 |